epiglucan and Cardiotoxicity

epiglucan has been researched along with Cardiotoxicity* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Cardiotoxicity

ArticleYear
Natural Polysaccharide
    Nutrients, 2022, Feb-21, Volume: 14, Issue:4

    Doxorubicin (DOXO) can be used to treat a variety of human tumors, but its clinical application is limited due to severe cardiotoxic side effect. Here, we explore the role of

    Topics: Animals; beta-Glucans; Cardiotoxicity; Doxorubicin; Mice; Myocytes, Cardiac; Oxidative Stress; Polysaccharides

2022